Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer
Phase 2
- Conditions
- Advanced Colorectal Carcinoma
- Interventions
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 136
- Registration Number
- NCT04582981
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer
Phase 2
- Conditions
- Pancreatic CancerChemotherapy Effect
- Interventions
- First Posted Date
- 2020-10-09
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 120
- Registration Number
- NCT04581876
- Locations
- 🇨🇳
Fudan University, Shanghai, Shanghai, China
Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation
Not Applicable
- Conditions
- Intraoperative MonitoringThyroid CancerParathyroid
- Interventions
- Device: Intraoperative parathyroid gland auxiliary recognition system
- First Posted Date
- 2020-09-23
- Last Posted Date
- 2020-09-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 200
- Registration Number
- NCT04560426
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
The Value of ctDNA on Chemotherapy Efficacy for mCRC
Not Applicable
Recruiting
- Conditions
- Circulating Tumor DNA
- Interventions
- Genetic: ct-DNA
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 300
- Registration Number
- NCT04555369
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Eribulin in mTNBC Patients
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2021-02-03
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 208
- Registration Number
- NCT04541420
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients
Phase 2
Recruiting
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 90
- Registration Number
- NCT04537286
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer
Phase 2
- Conditions
- Colorectal Cancer
- Interventions
- Radiation: Stereotactic Ablative Radiotherapy (SABR)
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT04535024
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Methylene Blue and Postoperative Neurocognitive Disorders
Not Applicable
Completed
- Conditions
- Postoperative Delirium
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 314
- Registration Number
- NCT04529265
- Locations
- 🇨🇳
Shanghai Cancer Center, Fudan University, Shanghai, China
SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)
Not Applicable
Recruiting
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Procedure: Systematically mediastinal lymph node dissectionProcedure: No mediastinal lymph node dissection
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 638
- Registration Number
- NCT04527419
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients
- Conditions
- Liver MetastasesColorectal Cancer
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 116
- Registration Number
- NCT04525313
© Copyright 2025. All Rights Reserved by MedPath